These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16394088)

  • 1. Visfatin is an adipokine, but it is not regulated by thiazolidinediones.
    Hammarstedt A; Pihlajamäki J; Rotter Sopasakis V; Gogg S; Jansson PA; Laakso M; Smith U
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1181-4. PubMed ID: 16394088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
    Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
    Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
    Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.
    McGee KC; Harte AL; da Silva NF; Al-Daghri N; Creely SJ; Kusminski CM; Tripathi G; Levick PL; Khanolkar M; Evans M; Chittari MV; Patel V; Kumar S; McTernan PG
    PLoS One; 2011; 6(6):e20287. PubMed ID: 21694775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
    Lv Q; Wang Y; Wang W; Wang L; Zhou X
    Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
    Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
    Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.
    Tonelli J; Li W; Kishore P; Pajvani UB; Kwon E; Weaver C; Scherer PE; Hawkins M
    Diabetes; 2004 Jun; 53(6):1621-9. PubMed ID: 15161771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.
    Hammarstedt A; Pihlajamäki J; Graham TE; Kainulainen S; Kahn BB; Laakso M; Smith U
    J Intern Med; 2008 Apr; 263(4):440-9. PubMed ID: 18324929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.
    Pfützner A; Marx N; Walcher D; Löbig M; Seidel D; Forst T
    Clin Lab; 2008; 54(7-8):237-41. PubMed ID: 18942491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
    Koenen TB; Tack CJ; Kroese JM; Hermus AR; Sweep FC; van der Laak J; Stalenhoef AF; de Graaf J; van Tits LJ; Stienstra R
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4453-7. PubMed ID: 19820024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
    Varma V; Yao-Borengasser A; Rasouli N; Bodles AM; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; McGehee RE; Fried SK; Kern PA
    J Clin Endocrinol Metab; 2007 Feb; 92(2):666-72. PubMed ID: 17090638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
    Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ
    J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
    Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.
    Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
    Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.